Minimally Invasive Liver Surgery for Metastases From Colorectal Cancer: Oncologic Outcome and Prognostic Factors

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01356706

Enrollment

274

Registered

2011-05-19

Start date

2002-10-31

Completion date

2012-07-31

Last updated

2012-07-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Long-term Oncologic Outcome of MILS in Patients With CRLM and Prognostic Indicators

Keywords

liver metastases, colorectal cancer, surgery, prognosis

Brief summary

Only few reports exist on long-term survival after minimally invasive liver surgery (MILS for colorectal liver metastases. No data are available assessing prognostic factors in the era of current modern treatment strategies. The aim of the current study is to analyze the long-term oncologic outcome after MILS for metastases from colorectal cancer and determine prognostic indicators.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 90 Years

Healthy volunteers

Inclusion criteria

* Patients with CRLM * Surgery: resection and/or ablation * preoperative chemotherapy and/or biological agents are allowed * postoperative chemotherapy and/or biological agents are allowed * simultaneous colorectal resection is allowed

Exclusion criteria

* primary liver cancer * benign liver tumors * pregnancy

Design outcomes

Primary

Measure	Time frame
overall survival	5 years

Secondary

Measure	Time frame
prognostic variables	5 year

Countries

Belgium

Outcome results